Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00034801
First received: May 2, 2002
Last updated: July 18, 2006
Last verified: July 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2003
  Estimated Primary Completion Date: No date given